new molecules and indications for glp 1 medicines GLP-1 Receptor Agonists A glimpse of the future:

That night I was also struck by the fact that here was a 12,000 square feet store and all the customers were lined up at the pharmacy counter in the back

Competition among drugmakers has resulted in other new drugs, including Zepbound which spurs even greater weight loss than Wegovy

10.1016/j.molmet.2019.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar] Nguyen, A

Cardiometabolic Profiles of Oral and Subcutaneous GLP-1 Receptor Mono-Agonists in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis

Studies designed to explicitly examine glucose-centric vs weight-centric approaches to diabetes management are needed

What we didnt know was how these medications might influence cancer risk in obese patients without diabetes. To answer that question, the research team used a target trial emulation approach an emerging method designed to approximate the rigor of a randomized clinical trial using real-world data